SCHEMBL656300

SCHEMBL656300

O=C(O)C=C(c1ccccc1)c1cc2cc(Cl)ccc2s1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 4/20 0.48
CLK1 P49759 3/20 0.48
DYRK1B Q9Y463 3/20 0.48
HDAC1 Q13547 5/20 0.43
BCL2L1 Q07817 1/20 0.42
PDPK1 O15530 2/20 0.40
CHRNA7 P36544 2/20 0.40
HTR3A P46098 2/20 0.40
F10 P00742 1/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
TBXAS1 P24557 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10252866 1.00 DYRK1A (0.48) DYRK1ACLK1DYRK1BHDAC1BCL2L1
SCHEMBL10286931 1.00 DYRK1A (0.48) DYRK1ACLK1DYRK1BHDAC1BCL2L1
SCHEMBL2305184 0.83 CLK1 (0.41) DYRK1ACLK1DYRK1BHDAC1CHRNA7
SCHEMBL657185 0.81 DYRK1A (0.70) DYRK1ACLK1DYRK1BHDAC1BCL2L1
SCHEMBL10252922 0.81 CLK1 (0.42) DYRK1ACLK1DYRK1BHDAC1BCL2L1
SCHEMBL29742302 0.76 BCL2L1 (0.59) DYRK1ACLK1DYRK1BBCL2L1CHRNA7
SCHEMBL740202 0.76 BCL2L1 (0.59) DYRK1ACLK1DYRK1BBCL2L1CHRNA7
SCHEMBL17267445 0.73 CHRNA7 (0.46) DYRK1ACLK1DYRK1BHDAC1BCL2L1
SCHEMBL11328609 0.72 CES2 (0.61) PDPK1MEN1KMT2A
SCHEMBL656299 0.72 PDPK1 (0.42) PDPK1MEN1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP claimed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US claimed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP claimed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO claimed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP claimed
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB DYRK1A 504/4885CLK1 378/4885DYRK1B 578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.